back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-07 19:29 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
400,000 | ||
| Filed 2024-03-07 19:24 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-07 19:23 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+400,000 vol |
||
| Filed 2024-03-05 20:16 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+400,000 vol |
||
| Filed 2023-09-13 11:14 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-05 20:16 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+400,000 vol |
2,400,000 | |
| Filed 2023-09-13 11:14 Tx date 2020-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
KOZIKOWSKI, ALAN
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2021-12-31 19:30 Tx date 2021-12-30 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,110
+500 vol $4.22 each |
2,002,500 | |
| Filed 2021-12-29 20:34 Tx date 2021-12-28 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,050
+500 vol $4.10 each |
2,002,000 | |
| Filed 2021-12-10 10:06 Tx date 2021-12-09 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,405
+500 vol $4.81 each |
2,001,500 | |
| Filed 2021-12-06 15:47 Tx date 2021-12-06 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,240
+1,000 vol $5.24 each |
2,001,000 | |
| Filed 2021-04-26 18:30 Tx date 2021-04-26 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$50,000
+1,000,000 vol $0.05 each |
2,000,000 | |
| Filed 2021-04-26 18:27 Tx date 2021-04-26 |
$DRUG
Bright Minds Biosciences Inc. |
Kozikowski, Alan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-50,000
-1,000,000 vol $0.05 each |
0 | |
| Filed 2021-02-01 17:03 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Kozikowski, Alan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2021-02-01 15:09 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Kozikowski, Alan
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |